Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Survey Study: Exploring Adoption Rates of the 2022 I.C.C and W.H.O Myeloid Neoplasm Classifications in the U.S

Hadil Zureigat, Daniel P. Nurse, Mariah Odneck, Bridget Adcock, Asad Rauf, Heya Batah, Bianca Honnekeri, Xuefei Jia, MaryBeth Mercer, Samer Al Hadidi, Kamran M. Mirza, Moaath K. Mustafa-Ali

Blood (2023) 142 (Supplement 1): 7293.

https://doi.org/10.1182/blood-2023-190547

Published: 2023

Journal Articles

Risk of Myelodysplastic Syndromes (MDS) in Adolescents and Young Adults with Cancers Treated with Chemotherapy with or without Radiotherapy

Rahul Mishra, Xuefei Jia, Debolina Pramanik, Abhay Singh, Sindhusha Veeraballi, Sophia Balderman, John C Molina, Anjali S. Advani, Moaath K. Mustafa-Ali, Hetty E. Carraway, Aaron T. Gerds, Nargiz F Muganlinskaya, Sudipto Mukherjee

Blood (2023) 142 (Supplement 1): 2351.

https://doi.org/10.1182/blood-2023-190692

Published: 2023

Journal Articles

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

Danai Dima, Fauzia Ullah, Serhan Unlu, Diana Basali, Mahir Khan, Abdullah Saeed Khan, Xuefei Jia, Majid Jaberi-Douraki, Beth M. Faiman, Sandra Mazzoni, Louis S. Williams, Christy J. Samaras, Jason Valent, Faiz Anwer, Jack Khouri, Shahzad Raza

Blood (2023) 142 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2023-181365

Published: 2023

Journal Articles

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Robert M. Dean, Deepa Jagadeesh, Kasra Karamlou, Chieh-Lin Fu, Allison Winter, Ethan Krauspe, Jonathan Zhou, Taylor R. Brooks, Merve Kacar, Ben K. Tomlinson, Brenda W Cooper, Hong Li, Xuefei Jia, Yanwen Chen, Jenna Thomas, Paolo F. Caimi

Blood (2023) 142 (Supplement 1): 3087.

https://doi.org/10.1182/blood-2023-173943

Published: 2023

Journal Articles

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-136101

Published: 2020

Journal Articles

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Doaa Attia, MD, Xuefei Jia, MS, Mailey L Wilks, DNP, MSN, APRN, Barbara Tripp, APRN, CNS, Christopher D'Andrea, PA-C, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-142805

Published: 2020

Journal Articles

Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia

Rachel Hu, MD, Aziz Nazha, Xuefei Jia, MS, Brian P. Hobbs, PhD, Hetty E. Carraway, MD MBA, Sudipto Mukherjee, MDPhDMPH, Aaron T. Gerds, MDMS, Anjali S. Advani, MD, Yasunobu Nagata, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Babal K. Jha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 1527.

https://doi.org/10.1182/blood-2018-99-114273

Published: 2018

Journal Articles

Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis

Mailey L Wilks, MSN, APRN, NP-C, Shyam K. Poudel, MD, Deborah Y. Park, BS, Xuefei Jia, MS, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barb Tripp, CNS, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 3570.

https://doi.org/10.1182/blood-2018-99-117338

Published: 2018

Journal Articles

Evaluating the Evidence for Long-Term Benefit from Specialty Centers Versus Real World for MDS Patients Treated with HMA

Sudipto Mukherjee, MD PhD MPH, Tomas Radivoyevitch, PhD, Brian P. Hobbs, PhD, Xuefei Jia, MS, Rami S. Komrokji, MD, David P. Steensma, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, Guillermo Garcia-Manero, MD, Jaroslaw P. Maciejewski, Aziz Nazha, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 3095.

https://doi.org/10.1182/blood-2018-99-119146

Published: 2018

Journal Articles

Does Trial Participation Improve Outcomes for Higher-Risk Myelodysplastic Syndromes (MDS) Patients Treated at Specialty Centers?

Sudipto Mukherjee, MD PhD MPH, David P. Steensma, MD, Rami S. Komrokji, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, Guillermo Garcia-Manero, MD, Aziz Nazha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, MD MS, Brian P. Hobbs, PhD, Xuefei Jia, MS

Blood (2018) 132 (Supplement 1): 3096.

https://doi.org/10.1182/blood-2018-99-117174

Published: 2018

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Shyam K. Poudel, MD, Xuefei Jia, MS, Deborah Y. Park, BS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, AOCN, Jung-Min Song, RN, CNS, Keith R. McCrae, MD, Alok A. Khorana, MD, Dana E. Angelini, MD

Blood (2018) 132 (Supplement 1): 4809.

https://doi.org/10.1182/blood-2018-99-114897

Published: 2018

Journal Articles

Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

Madeline Waldron, PharmD, Caitlin Siebenaller, PharmD, Marc Earl, PharmD, Xuefei Jia, MS, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Barb Tripp, CNS, Brian P. Hobbs, PhD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2018) 132 (Supplement 1): 4806.

https://doi.org/10.1182/blood-2018-99-115257

Published: 2018

Journal Articles

IPI, Comorbidity Index, Hospitalization for Treatment-Related Adverse Events Are Predictors for Outcome in Elderly Diffuse Large B Cell Lymphoma Patients

Caner Saygin, MD, Xuefei Jia, MS, Brian T. Hill, MD PhD, Robert M. Dean, MD, Bhumika Patel, MD, Brad Pohlman, MD, Mitchell R. Smith, Deepa Jagadeesh, MD MPH

Blood (2016) 128 (22): 1860.

https://doi.org/10.1182/blood.V128.22.1860.1860

Published: 2016

Journal Articles

Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)

Blood (2015) 126 (23): 2536.

https://doi.org/10.1182/blood.V126.23.2536.2536

Published: 2015

Journal Articles

Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia

Naresh Bumma, MD, Jing Ai, MD PhD, Xuefei Jia, MS, Sean Hobson, MA, Donna Abounader, Mikkael A. Sekeres, MD MS, Matt E. Kalaycio, MD, Ron Sobecks, MD, Aaron Gerds, MDMS, Betty K. Hamilton, MD, Sudipto Mukherjee, MD PhD MPH, Hetty E. Carraway, MD, Shawnda Tench, Edward A. Copelan, MD, Anjali S. Advani, MD

Blood (2014) 124 (21): 5256.

https://doi.org/10.1182/blood.V124.21.5256.5256

Published: 2014

NARROW

Survey Study: Exploring Adoption Rates of the 2022 I.C.C and W.H.O Myeloid Neoplasm Classifications in the U.S

Risk of Myelodysplastic Syndromes (MDS) in Adolescents and Young Adults with Cancers Treated with Chemotherapy with or without Radiotherapy

Insights into Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: A 12-Year Experience of a Large Academic Center

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Frequency of Arterial Thromboemobolic Events in Patients with Cancer Associated Venous Thromboembolism

Risk of Recurrent Venous Thromboembolism and Bleeding in Patients with Cancer Associated Thrombosis

Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia

Deaths Due to Thrombotic Versus Bleeding Events within 90 Days of Cancer Associated Thrombosis

Evaluating the Evidence for Long-Term Benefit from Specialty Centers Versus Real World for MDS Patients Treated with HMA

Does Trial Participation Improve Outcomes for Higher-Risk Myelodysplastic Syndromes (MDS) Patients Treated at Specialty Centers?

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Clinical Outcomes of Isolated Distal Deep Vein Thrombosis Associated with Cancer: The Cleveland Clinic Experience

Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

IPI, Comorbidity Index, Hospitalization for Treatment-Related Adverse Events Are Predictors for Outcome in Elderly Diffuse Large B Cell Lymphoma Patients

Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)

Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only